glutathione and pulmonary hypertension Pathophysiology of Group 3 Associated with Lung Diseases and/or Hypoxia Frontiers | Hydrogen sulfide as
Frontiers Hydrogen sulfide as a new therapeutic target of pulmonary hypertension: an overview with update on immunomodulation Strategizing Drug Therapies in Pulmonary Hypertension for Improved Outcomes Immunotherapy of Endothelin 1 Receptor Type A for Pulmonary Arterial Hypertension JACC The molecular targets of approved treatments for pulmonary arterial hypertension Thorax Epidemiology and treatment of pulmonary arterial hypertension Nature Reviews Cardiology
Pay in 4 interest-free payments of $6.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




